Investigators recently inspected the company’s facility and found poor sterile production practices, which resulted in the initial product alert. This week that alert was expanded.
The agency has not learned of any adverse events from improperly sterilized NuVision products. The alert is cautionary.
More Articles on Anesthesia:
FDA Changes Label, Lowers Dose Recommendation for Zolpidem Insomnia Drug
Masimo Announces Clinical Study Outcomes at International Anesthesia Research Society Meeting
Physician Office Partners Releases Billing Solution for Anesthesia Practices
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
